What is Ryzodeg, and why patents matter in India?
Ryzodeg is an insulin product. Patent status in India determines when companies can legally market a generic or biosimilar version without infringing the original drug’s intellectual property, subject to any additional regulatory and exclusivity considerations.
Current patent status of Ryzodeg in India (what’s available to check)
DrugPatentWatch.com tracks patent-related information by country and includes India-specific data for some brands. You can use it to see whether patents (and related filings) are listed as active, expired, or under challenge for Ryzodeg in India.
For the most accurate, up-to-date status, check Ryzodeg on DrugPatentWatch.com here:
https://www.drugpatentwatch.com/ (search for “Ryzodeg” within the site)
How to interpret “active” vs “expired” for an Indian Ryzodeg patent
When you find a listed India record on DrugPatentWatch.com (or another patent database), the key fields to interpret are:
- Whether the specific patent term is still running (not yet expired).
- Whether the patent has lapsed due to non-payment/other formal reasons.
- Whether another filing exists with a later expiry that could still block market entry.
- Whether there is litigation or a formal challenge that changes enforceability in practice.
What happens if a patent is expired in India?
If the relevant Indian patents for the product are expired or no longer enforceable, biosimilar/generic manufacturers may still need:
- Approval from India’s drug regulator (for insulin products, the approval path still depends on demonstrating quality, safety, and efficacy comparability).
- Compliance with any remaining secondary IP (for example, process or formulation patents, if they exist separately).
What to search next if you’re trying to forecast market entry
To forecast when competitors could enter, search for these adjacent items in India for the same insulin product:
- “compound” (active ingredient) patents
- formulation/device-related patents (if applicable)
- process patents
- divisional or continuation-type filings that extend protection
- any patent oppositions or court actions noted in public records
Limits of what can be stated without the exact patent records
Patent status depends on the specific Ryzodeg patent numbers/families listed for India and their individual expiry dates. Those details are best confirmed on the India-specific patent record pages (for example via DrugPatentWatch.com’s India view).
Sources
- https://www.drugpatentwatch.com/